Prima BioMed (PBMD) Announces Japanese Patent for IMP321 in Cancer
Tweet Send to a Friend
Prima BioMed Ltd (NASDAQ: PBMD) announces the granting of patent number 5908210 entitled "Use of Recombinant LAG-3 or the Derivatives ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
